Sabra Health Care REIT, Inc.

    Jurisdiction
    United States
    LEI
    549300E3BC7GU7TAZ621
    ISIN
    US78573L1061 (SBRA)
    Sectors
    1. Real Estate
    2. REIT - Healthcare Facilities

    Scores

    InsiderPie Expert Score
    trending_flat 52 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €14.90 3.6% overvalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €628.95M
    Gross margin
    76.9%
    EBIT
    €321.39M
    EBIT margin
    51.1%
    Net income
    €156.44M
    Net margin
    24.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €695.96M +10.7% €174.95M +11.8%
    €773.15M +11.1% €190.89M +9.1%
    €857.80M +10.9% €203.02M +6.4%

    Dividends

    Last dividend amount
    $0.30
    Ex date
    Payment date
    Dividend payout ratio
    155.8%

    Earnings Calls

    Latest earnings call: May 9, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 1.4M $24.84M +24K Buy

    Add to watchlist

    Notifications